First Institute for Drug Research in Israel opens at HU
The Hebrew University of Jerusalem celebrated the founding of its Institute for Drug Research – the only one of its kind in Israel.
If you are interested in drug research and development this is where some of the new generation of leading scientists in the field of drug research will be flocking. The IDR will encourages multi-disciplinary research groups to form to advance scientific excellence and will bring together special multi-disciplinary teams to solve complex problems. The IDR will also partner with the pharmaceutical industry in new initiatives, contributing its unique and invaluable experience and knowledge.
As teams and individuals, the institute’s researchers have discovered new drugs and invented novel drug-delivery platforms for the treatment of a variety of clinical disorders. These pathologies include allergies, cancer, age related and neurological diseases, brain trauma, diabetes and drug addiction.
Over the years, 13 start-up companies have been established based on research of the institute’s current research staff. Collectively, the institute’s scientists have registered more than 200 patents, totaling more than 25% of all approved patent applications of the Hebrew University.
Today, four novel drugs, developed by the institute’s researchers and commercialized by Yissum, the research and development company of the Hebrew University, are in the market. The most well-known is Exelon, a drug which delays the onset of the symptoms of Alzheimer’s disease. Several other drugs are currently in various stages of development, including clinical and preclinical trials.
היי, אני חושב לעשות שנה של המחקר בירושלים, אני מתעניין המחלקה החדש הזה, תהיתי, איזה כישורים אני צריך להיכנס ולא היה רוצה לשמוע קצת יותר על הנושא